How much patients benefit from the new immuno-therapy treatment announced today in the fight against cancer will depend on which drugs suit them best, according to a leading expert.
Speaking to ITV News, Dr Alan Worsley of Cancer Research UK said that patients might respond best to one type of drug or a combination of therapies.
Discovery of an immuno-based therapy has been hailed as a breakthrough in the fight against cancer. We look at other major developments
A pair of cancer drugs can shrink tumours in more than half of patients with an advanced form of skin cancer, according to new research.